ADEXUSDx® COVID-19 Antibody Test Receives FDA Emergency Use Authorization for Point-of-Care Deployment Across U.S.
SPRINGDALE, AR, May 26, 2021 – NOWDiagnostics, Inc. announced today that it has received Emergency Use Authorization (EUA) for its ADEXUSDx® COVID-19 antibody test for use
Self-Contained, Rapid ADEXUSDx® COVID-19 Antibody Fingerstick Test Receives CE Mark for Deployment Across European Union
SPRINGDALE, AR, December 17, 2020 – Effective December 8, 2020, NOWDiagnostics, Inc. has received Conformité Européene (CE) mark approval for its ADEXUSDx® COVID-19 ‘antibody fingerstick’
SPRINGDALE, Ark., Dec. 10, 2020 /PRNewswire/ — NOWDiagnostics, Inc. announced today that it has filed for expanded Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA)
ADEXUSDx® COVID-19 Antibody Test Filed for Emergency Use Authorization Confirmed 100% Accurate with BEI Panel
SPRINGDALE, Ark., Dec. 7, 2020 /PRNewswire/ — NOWDiagnostics, Inc. announced today that study results for its ADEXUSDx® COVID-19 antibody test yielded encouraging test performance—providing a strong use case for the
Whether one has long-term immunity to COVID-19 after recovering from the virus is unclear amid a lack of scientific evidence. Still, antibodies might be the